The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction
Abstract
Increased blood flow and vascular leakage of proteins preferentially affect tissues that are sites of diabetic complications in humans and animals. These vascular changes in diabetic rats are largely prevented by aminoguanidine. Glucose-induced vascular changes in nondiabetic rats are also prevented by aminoguanidine and by NG-monomethyl-L-arginine (NMMA), an established inhibitor of nitric oxide (NO·) formation from L-arginine. Aminoguanidine and NMMA are equipotent inhibitors of interleukin-1 β-induced 1) nitrite formation (an oxidation product of NO·) and cGMP accumulation by the rat β-cell insulinoma cell line RINm5F, and 2) inhibition of glucose-stimulated insulin secretion and formation of iron-nitrosyl complexes by islets of Langerhans. In contrast, NMMA is ∼ 40 times more potent than aminoquanidine in elevating blood pressure in nondiabetic rats. These results demonstrate that aminoguanidine inhibits NO. production and suggest a role for NO· in the pathogenesis of diabetic vascular complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Bucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking
Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., & Cerami, A. (1986) · Science · doi:10.1126/science.3487117 · Cited by 1,146
EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages
Lancaster, J. R., & Hibbs, J. B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1223 · Cited by 507
Self-citationSoulis-Liparota, T., Cooper, M., Papazoglou, D., Clarke, B., & Jerums, G. (1991) · Diabetes · doi:10.2337/diab.40.10.1328 · Cited by 447
Drapier, J. C., Pellat, C., & Henry, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99204-5 · Cited by 279
Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TxA2
Tesfamariam, B., Jakubowski, J. A., & Cohen, R. A. (1989) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1989.257.5.h1327 · Cited by 243
Kihara, M., Schmelzer, J. D., Poduslo, J. F., Curran, G. L., Nickander, K. K., & Low, P. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6107 · Cited by 207
Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels.
Wolf, B. A., Williamson, J. R., Easom, R. A., Chang, K., Sherman, W. R., & Turk, J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci114988 · Cited by 185
Self-citationGlucose‐induced metabolic imbalances in the pathogenesis of diabetic vascular disease
Pugliese, G., Tilton, R. G., & Williamson, J. R. (1991) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610070106 · Cited by 146
Self-citation
Cited by
A Rapid, Simple Spectrophotometric Method for Simultaneous Detection of Nitrate and Nitrite
Miranda, K. M., Espey, M. G., & Wink, D. A. (2001) · Nitric Oxide · doi:10.1006/niox.2000.0319 · Cited by 3,860
Nitric oxide activates cyclooxygenase enzymes.
Salvemini, D., Misko, T. P., Masferrer, J. L., Seibert, K., Currie, M. G., & Needleman, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7240 · Cited by 1,395
Advanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Nitric Oxide Synthases: Properties and Catalytic Mechanism
Griffith, O. W., & Stuehr, D. J. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003423 · Cited by 1,311
Hyperglycemic Pseudohypoxia and Diabetic Complications
Williamson, J. R., Chang, K., Frangos, M., Hasan, K. S., Ido, Y., Kawamura, T., Nyengaard, J. R., Den Enden, M. V., Kilo, C., & Tilton, R. G. (1993) · Diabetes · doi:10.2337/diab.42.6.801 · Cited by 1,105
Self-citationInducible nitric oxide synthase: Regulation, structure, and inhibition
Cinelli, M. A., Do, H. T., Miley, G. P., & Silverman, R. B. (2020) · Medicinal Research Reviews · doi:10.1002/med.21599 · Cited by 889
Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
Misko, T. P., Moore, W. M., Kasten, T. P., Nickols, G. A., Corbett, J. A., Tilton, R. G., McDaniel, M. L., Williamson, J. R., & Currie, M. G. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90357-n · Cited by 721
Self-citationKern, T. S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/95103 · Cited by 614
INHIBITION OF NITRIC OXIDE SYNTHASE AS A POTENTIAL THERAPEUTIC TARGET
Hobbs, A. J., Higgs, A., & Moncada, S. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.191 · Cited by 596
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms
Southan, G. J., & Szabó, C. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02099-3 · Cited by 569
Yabe-Nishimura, C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01347-4 · Cited by 526
Molecular mechanisms of ageing in connective tissues
Bailey, A. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00225-1 · Cited by 522
Nitric oxide: A radical neurotransmitter in the central nervous system
Vincent, S. R. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90023-x · Cited by 463
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.
Vlassara, H., Striker, L. J., Teichberg, S., Fuh, H., Li, Y. M., & Steffes, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11704 · Cited by 462
Mechanisms of circulatory and intestinal barrier dysfunction during whole body hyperthermia
Hall, D. M., Buettner, G. R., Oberley, L. W., Xu, L., Matthes, R. D., & Gisolfi, C. V. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.2.h509 · Cited by 461
Titheradge, M. A. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00031-6 · Cited by 457
Corbett, J. A., Sweetland, M. A., Wang, J. L., Lancaster, J. R., & McDaniel, M. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1731 · Cited by 411
Self-citationEffects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis
Chan, J., Tanaka, K., Carroll, D., Flynn, J., & Bloom, B. R. (1995) · Infection and Immunity · doi:10.1128/iai.63.2.736-740.1995 · Cited by 407
Szabó, C., Southan, G. J., & Thiemermann, C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12472 · Cited by 406
Aminoguanidine selectively inhibits inducible nitric oxide synthase
Griffiths, M. J. D., Messent, M., MacAllister, R. J., & Evans, T. W. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13907.x · Cited by 397
Cross, A. H., Misko, T. P., Lin, R. F., Hickey, W. F., Trotter, J. L., & Tilton, R. G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117282 · Cited by 384
Self-citationNeufeld, A. H., Sawada, A., & Becker, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9944 · Cited by 374
Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors
Mollace, V., Muscoli, C., Masini, E., Cuzzocrea, S., & Salvemini, D. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.1 · Cited by 357
Novel inhibitors of advanced glycation endproducts
Rahbar, S., & Figarola, J. L. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.009 · Cited by 329
Cytokines suppress human islet function irrespective of their effects on nitric oxide generation.
Eizirik, D. L., Sandler, S., Welsh, N., Cetkovic-Cvrlje, M., Nieman, A., Geller, D. A., Pipeleers, D. G., Bendtzen, K., & Hellerström, C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117188 · Cited by 317
Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis
Forbes, J. M., Yee, L. T. L., Thallas, V., Lassila, M., Candido, R., Jandeleit-Dahm, K. A., Thomas, M. C., Burns, W. C., Deemer, E. K., Thorpe, S. R., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1813 · Cited by 314
Bolli, R., Manchikalapudi, S., Tang, X.-L., Takano, H., Qiu, Y., Guo, Y., Zhang, Q., & Jadoon, A. K. (1997) · Circulation Research · doi:10.1161/01.res.81.6.1094 · Cited by 313
Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation.
Salvemini, D., Seibert, K., Masferrer, J. L., Misko, T. P., Currie, M. G., & Needleman, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117185 · Cited by 306
Thiemermann, C. (1997) · General Pharmacology: The Vascular System · doi:10.1016/s0306-3623(96)00410-7 · Cited by 303
The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis
Padgett, L. E., Broniowska, K. A., Hansen, P. A., Corbett, J. A., & Tse, H. M. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06826.x · Cited by 288
Self-citationIsothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity
Southan, G. J., Szabó, C., & Thiemermann, C. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13256.x · Cited by 278
Pharmacological Inhibition of Diabetic Retinopathy
Kern, T. S., & Engerman, R. L. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1636 · Cited by 277
Lehnert, N., Kim, E., Dong, H. T., Harland, J. B., Hunt, A. P., Manickas, E. C., Oakley, K. M., Pham, J., Reed, G. C., & Alfaro, V. S. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00253 · Cited by 272
Takano, H., Manchikalapudi, S., Tang, X.-L., Qiu, Y., Rizvi, A., Jadoon, A. K., Zhang, Q., & Bolli, R. (1998) · Circulation · doi:10.1161/01.cir.98.5.441 · Cited by 256
Intervention against the Maillard reaction in vivo
Monnier, V. M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.014 · Cited by 196
Cameron, N. E., Cotter, M. A., & Maxfield, E. K. (1993) · Diabetologia · doi:10.1007/bf00400231 · Cited by 181
“Under some conditions aminoguanidine can also function as an aldose reductase inhibitor [16] and has also been suggested to be an inhibitor of nitric oxide synthase [ 17 ].”
BackgroundTakamura, T., Kato, I., Kimura, N., Nakazawa, T., Yonekura, H., Takasawa, S., & Okamoto, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2493 · Cited by 145
Role of Ferroportin in Macrophage-Mediated Immunity
Johnson, E. E., Sandgren, A., Cherayil, B. J., Murray, M., & Wessling-Resnick, M. (2010) · Infection and Immunity · doi:10.1128/iai.00498-10 · Cited by 68
Metadata
- Authors
- Corbett, J. A., Tilton, R. G., Chang, K., Hasan, K. S., Ido, Y., Wang, J. L., Sweetland, M. A., Lancaster, J. R., Williamson, J. R., & McDaniel, M. L.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1992-04-01
- Volume
- 41
- Issue
- 4
- Pages
- 552-556
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2077824574
- Cited by
- 628
- References
- 10
- FWCI
- 27.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.